Menu Search
Equities

Primary Health Properties PLC

PP51:BER

Primary Health Properties PLC

Actions
  • Price (EUR)1.13
  • Today's Change0.011 / 0.98%
  • Shares traded--
  • 1 Year change+0.62%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024 18:27 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Primary Health Properties PLC is a United Kingdom-based real estate investment trust (REIT). The Company invests primary in healthcare accommodation across the United Kingdom and Ireland leased principally to GPs, government healthcare organizations and other associated healthcare users. The Company provides a range of services, including acquisition and development, property management, landlord and tenant, asset management, and finance. Its property portfolio includes Primrose Lane Medical Centre, Scotland; Pinfold Health Centre, Bloxwich; St Johns Medical Centre, Walsall Wood; Kilnamanagh Primary Care Centre, Republic of Ireland; Leap Valley Medical Centre, Bristol; Gracemount Medical Centre, Edinburgh; White Rose Medical Centre, New Tredegar; Old Kilpatrick Medical Practice, Glasgow; Watlington Medical Centre, Watlington; Horley Health Centre, Horley; The Manor Practice, Brighton; Barlow Medical Centre, Manchester; West Derby Medical Centre, North West; among others.

  • Revenue in GBP (TTM)177.80m
  • Net income in GBP-8.60m
  • Incorporated1995
  • Employees60.00
  • Location
    Primary Health Properties PLCFifth floorBurdett House, 15-16 Buckingham StreetLONDON WC2N 6DUUnited KingdomGBR
  • Phone+44 203 824 1841
  • Fax+44 207 451 7051
  • Websitehttps://www.phpgroup.co.uk/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.